0
0
Home » Medical Devices » In Vitro Diagnostics

Treponema Pallidum Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

The treponema pallidum tests market size was $437.3 million in 2021. The treponema pallidum tests market research report is built to visualize quantitative market trends within in vitro diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Treponema Pallidum Tests market for the year 2020 and beyond. Syphilis is a type of sexually transmitted disease which can lead to long-term health complications if left untreated.

Treponema Pallidum Tests Market Size For more insights, download a free report sample

Which are the key regions in the treponema pallidum tests market?

The key regions in the treponema pallidum tests market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

Which are the key segments in the treponema pallidum tests market?

The key segments in the treponema pallidum tests market are Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Fluorescent Treponemal Antibody Absorption (FTA-ABS) Tests, Other Tests, Rapid Plasma Reagin (RPR) Tests, Treponema Pallidum Hemagglutination (TPHA) Tests, Treponema Passive Particle Agglutination (TPPA) Tests, Unheated Serum Reagin (USR) Tests, and Venereal Disease Research Laboratory (VDRL) Tests. Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests has the highest market share in the treponema pallidum tests market.

Treponema pallidum tests market, by segments

Treponema pallidum tests market, by segmentsFor more segment insights, download a free report sample

Which are the key companies in the treponema pallidum tests market?

The key companies in the treponema pallidum tests market are Becton Dickinson and Co, Abbott Laboratories, Siemens AG, Bio-Rad Laboratories Inc, H.U. Group Holdings Inc, Trinity Biotech Plc, Arlington Scientific, Inc., and F. Hoffmann-La Roche Ltd.

Treponema pallidum tests market, by companies

Treponema pallidum tests market, by companiesTo know more about key companies, download a free report sample

Market report overview

Market size $437.3 million
Key regions North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa
Key segments Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Fluorescent Treponemal Antibody Absorption (FTA-ABS) Tests, Other Tests, Rapid Plasma Reagin (RPR) Tests, Treponema Pallidum Hemagglutination (TPHA) Tests, Treponema Passive Particle Agglutination (TPPA) Tests, Unheated Serum Reagin (USR) Tests, and Venereal Disease Research Laboratory (VDRL) Tests
key companies Becton Dickinson and Co, Abbott Laboratories, Siemens AG, Bio-Rad Laboratories Inc, H.U. Group Holdings Inc, Trinity Biotech Plc, Arlington Scientific, Inc., and F. Hoffmann-La Roche Ltd

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:

  • CMO executives who must have deep understanding of the Treponema Pallidum Tests market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to:

  • Understand the impact of COVID-19 on Treponema Pallidum Tests market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Treponema Pallidum Tests market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Treponema Pallidum Tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Treponema Pallidum Tests market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Key Players

Becton Dickinson and Co

Abbott Laboratories

Siemens AG

Bio-Rad Laboratories Inc

H.U. Group Holdings Inc

Trinity Biotech Plc

Arlington Scientific, Inc.

F. Hoffmann-La Roche Ltd

Tecan Group Ltd

PerkinElmer Inc

Cardinal Health Inc

bioMerieux SA

DiaSorin SpA

Omega Diagnostics Group Plc

Rapid Labs Ltd

Deben Diagnostics Ltd

Lorne Laboratories Ltd

Werfen Life Group SAU

Sekisui Diagnostics LLC

Frequently Asked Questions

The treponema pallidum tests market size was valued at $437.3 million in the year 2021.

The key regions in the treponema pallidum tests market are North America, Europe, South & Central America, Asia-Pacific, and Middle East & Africa.

The key segments in the treponema pallidum tests market are Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Tests, Fluorescent Treponemal Antibody Absorption (FTA-ABS) Tests, Other Tests, Rapid Plasma Reagin (RPR) Tests, Treponema Pallidum Hemagglutination (TPHA) Tests, Treponema Passive Particle Agglutination (TPPA) Tests, Unheated Serum Reagin (USR) Tests, and Venereal Disease Research Laboratory (VDRL) Tests.

The key companies in the treponema pallidum tests market are Becton Dickinson and Co, Abbott Laboratories, Siemens AG, Bio-Rad Laboratories Inc, H.U. Group Holdings Inc, Trinity Biotech Plc, Arlington Scientific, Inc., and F. Hoffmann-La Roche Ltd.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports